The oncogene erbb is a constitutively active form of a receptor tyrosine kinase that sends unregulated signals, from the plasma membrane, to stimulate cell proliferation. Suppose you have the capability to mutate all the copies of ras genes in these erbb-expressing cells, will this enhance or suppress the ability of erbb to promote tumor progression?.
